Cytomedix, Inc. (CMXI) (the “Company”), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announces the initiation of a Phase I clinical study with ...

more...

No comment yet.

Rescooped by Gilbert C FAURE from Immunology and Biotherapies

July 26, 2012 3:30 PM

Scoop.it!

Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results

From trialx.com - July 18, 2012 8:28 AM

Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results (#clinicaltrials Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results: Monoclon...)...

more...

No comment yet.

About

Resources

Terms

Mobile

Features

Media Kit
Contact Scoop.it
Blog

	Facebook
	X
	LinkedIn

Resources Center
Plans
1 Introduction

Terms of Use
Privacy Policy
Copyright Policy
Manage cookies

Websites & blogs
Knowledge Sharing
Personal branding
Content distribution
Content hubs
Content API

How do I publish content on my topic?

Easy to do! You can:

choose from suggestions on the right-side panel
publish any web site on the fly in 1-click (bookmarklet)
copy paste a link in the input box below
rescoop other curators’ content

Learn More

Why should I brand my topic?

Branding your topics will give more credibility to your content, position you as a professional expert and generate conversions and leads.

Learn more

Well suggest content based on your keywords

Examples:

To get content containing either thought or leadership enter:

To get content containing both thought and leadership enter:

To get content containing the expression thought leadership enter:

You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.

Learn more

How do I follow my topics performance?

Measuring and analyzing your curation will help you to understand what your audience is looking for and how to improve your performance.

Learn more